About 1,566,294 results (5,165 milliseconds)

KR20070095279A - Methods and compositions for treating ...

https://patents.google.com/patent/KR20070095279A/en
... high LDL, high cholesterol and / or high triglyceride levels. Hyperlipidemic ... direct or indirect lipid lowering activity, including cholesterol ...

WO2009103953A1 - Treatment of energy utilization disease ...

https://patents.google.com/patent/WO2009103953A1/en
High plasma levels of insulin and glucose due to insulin resistance ... Cholesterol drugs may be used to lower LDL cholesterol and triglyceride levels ...

AU2007200880A1 - Regulating lipid levels via the ZMAX1 or HBM ...

https://patents.google.com/patent/AU2007200880A1/en
... levels of triglycerides and LDL cholesterol and high levels of HDL cholesterol. ... direct injection into the liver or other cell involved in lipid ...

WO2014093622A2 - Delivery, engineering and optimization of ...

https://patents.google.com/patent/WO2014093622A2/en
... cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H] ... LDL receptors Human genes 0.000 description 3; 108010001831 LDL ...

US20140031304A1 - Anti-cholesterolemic compounds and methods ...

https://patents.google.com/patent/US20140031304A1/en
3 is a graph that shows the effect of EuMil on the plasma LDL cholesterol levels in rabbits. Rabbits were fed rabbit chow (control), fat fed (14% coconut oil ...

WO2018213708A1 - Systems, methods, and compositions for ...

https://patents.google.com/patent/WO2018213708A1/en
The study evaluated >700 guide RNA variants and SpCas9-induced indel mutation levels at >100 predicted genomic off-target loci in 293T and 293FT cells. The ...

WO2019071048A1 - Systems, methods, and compositions for ...

https://patents.google.com/patent/WO2019071048A1/en
In some embodiments, the composition further comprising a guide molecule which comprises a guide sequence linked to a direct repeat sequence, or a nucleotide ...

Traductor de Google

https://translate.google.com/?text&hl=es&sl=pt&langpair=pt
El servicio de Google, que se ofrece sin coste económico, traduce al instante palabras, frases y páginas web a más de 100 idiomas.

AU2014361826A1 - Delivery, use and therapeutic applications of ...

https://patents.google.com/patent/AU2014361826A1/en
Additional administrations of CRISPR enzyme mRNA and/or guide RNA might be useful to achieve the most efficient levels of genome modification. [0158J In one ...

EP2411030A1 - Process for the preparation of herbal extract of ...

https://patents.google.com/patent/EP2411030A1/en
Cho, IJ et al, in a research paper entitled "Hypolipidemic effect of soluble fiber isolated from seeds of Cassia tora Linn, in rats fed a high-cholesterol diet" ...

EP2411030A1 - Process for the preparation of herbal extract of ...

https://patents.google.com/patent/EP2411030A1/en
Cho, IJ et al, in a research paper entitled "Hypolipidemic effect of soluble fiber isolated from seeds of Cassia tora Linn, in rats fed a high-cholesterol diet" ...

AU2014281028B2 - Delivery and use of the CRISPR-Cas systems ...

https://patents.google.com/patent/AU2014281028B2/en
The study evaluated >700 guide RNA variants and SpCas9-induced indel mutation levels at >100 predicted genomic off-target loci in 293T and 293FT cells. The ...

WO2006052870A2 - High eicosapentaenoic acid producing strains ...

https://patents.google.com/patent/WO2006052870A2/en19
... LDL-cholesterol and increasing HDL- cholesterol (anti-arterial sclerosis action); EPA provides a natural approach to lower blood cholesterol and triglycerides.

WO2002005830A2 - Extracts from crassulacean acid metabolism ...

https://patents.google.com/patent/WO2002005830A2/en
As an example, none of the persons whose LDL andtriglyceride levels have responded to the use of these compositions made any special changes in their diet or ...

AU2004230485B2 - The severe acute respiratory syndrome ...

https://patents.google.com/patent/AU2004230485B2/en
after viral culture, or direct from patients), from a cell line source etc. ... high containment levels during performance of the assays and screening of ...

WO2006052870A2 - High eicosapentaenoic acid producing strains ...

https://patents.google.com/patent/WO2006052870A2/en
Microbial expression systems and expression vectors containing regulatory sequences that direct high-level ... LDL cholesterol (Harris, W.S. Amer. J. Clinical ...

WO2014143127A1 - Emulsion formulations - Google Patents

https://patents.google.com/patent/WO2014143127A1/en
... cholesterol by 13.3% and LDL-cholesterol by 12.5%. The HDL-cholesterol ... high (~150mM) lipid loads). The drug solubilization capacity of these ...

HU230435B1 - Use of substituted azetidinone compounds for ...

https://patents.google.com/patent/HU230435B1/en
PPARa activator compounds are useful in reducing trglitinase, moderately reducing LDL levels, and increasing HOL levels. Useful examples of PPAR ?, activators ...

WO1997024446A2 - Gene delivery vehicle-targeting ligands ...

https://patents.google.com/patent/WO1997024446A2/en
... LDL Receptor. In yet another alternative embodiment, the heterologous ... Alternatively, cells expressing high levels of EPO-b2m may be selected using ...

CA2915845A1 - Delivery, engineering and optimization of systems ...

https://patents.google.com/patent/CA2915845A1/en
variants and SpCas9-induced indel mutation levels at >100 predicted genomic off-target loci in 293T and 293FT cells. The authors that SpCas9 tolerates ...